US Patent Issued to The University of North Carolina at Chapel Hill, Texas Tech University System on April 22 for "Truncated dysferlin for treatment of dysferlinopathy" (North Carolina, Texas Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,145, issued on April 22, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.) and Texas Tech University System (Lubbock, Texas).

"Truncated dysferlin for treatment of dysferlinopathy" was invented by Matthew Louis Hirsch (Chapel Hill, N.C.) and R. Bryan Sutton (Lubbock, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to a truncated dysferlin nucleic acid and protein, vectors (e.g., adeno-associated virus vectors) comprising the nucleic acid and methods of using the same for delivery of dysferlin to a cell or a subject and treating dysferlinopathy."

The patent was filed on June 16, 2017, unde...